Lenox Hill Hospital has signed a two-year research alliance with Philips Medical Systems to collaborate on the development of advanced cardiovascular interventional technology. The collaboration will involve Philips' Allura Xper FD10 cardiac
Lenox Hill Hospital has signed a two-year research alliance with Philips Medical Systems to collaborate on the development of advanced cardiovascular interventional technology. The collaboration will involve Philips' Allura Xper FD10 cardiac catheterization lab and StentBoost, a stent imaging interventional tool. Much of the work will be done in the Lenox Hill Heart and Vascular Institute of New York City. The new collaboration, the outgrowth of a 15-year partnership between Lenox and Philips, will focus on a new image processing algorithm and how it can be used with the Allura Xper FD10 cath lab. The goal is to provide enhanced images of the heart that show lesions in greater detail. Philips' StentBoost will also be evaluated to assess its utility in stent placement.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.